Tag Archives: ATEC

Top 10 Heal Care Stocks For 2019

The Central Board of Trustees (CBT) of the Employees’ Provident Fund Organisation (EPFO) has suggested a reduction of interest rate on PF balances to 8.55% for 2017-18 as compared to 8.65% the year before. Two years ago, the EPFO paid 8.8% on EPF balances. How good is provident fund returns compared to returns in other products especially small savings instruments? Here are some of the features that make it an attractive savings options.

Despite the falling rates, EPF still holds saving advantage over other retirement savings fund. Kunal Bajaj is CEO & founder of Clearfunds.com said that it is backed by Government of India and secondly, while the rates may vary each year, they generally move around a small band. “Importantly, EPF  is tax-free during the period interest is earned as well as at the time of withdrawal,” he added.

Benefit of investing in EPF

EPF can be easily transferred from one company to the other through UAN (Universal Account Number) if one changes jobs. However, in case of PPF, changing the account from one bank to bank to another is a huge hassle if you go by anecdotal evidence. In case of fixed deposits, there is no portability among banks.

Top 10 Heal Care Stocks For 2019: Compugen Ltd.(CGEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Headlines about Compugen (NASDAQ:CGEN) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Compugen earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 47.9719981987303 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Joseph Griffin]

    Compugen (NASDAQ:CGEN) – Equities researchers at Jefferies Group increased their Q2 2018 earnings estimates for shares of Compugen in a research note issued on Wednesday, May 9th. Jefferies Group analyst P. Welford now anticipates that the biotechnology company will earn ($0.20) per share for the quarter, up from their prior forecast of ($0.21). Jefferies Group also issued estimates for Compugen’s Q4 2018 earnings at ($0.05) EPS, FY2018 earnings at ($0.46) EPS, FY2019 earnings at ($1.00) EPS, FY2020 earnings at ($1.19) EPS, FY2021 earnings at ($1.37) EPS and FY2022 earnings at ($1.58) EPS.

  • [By Chris Lange]

    Compugen Ltd. (NASDAQ: CGEN) shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb Co. (NYSE: BMY) will make a $12 million equity investment as part of its collaboration on a cancer trial.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Compugen (CGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks For 2019: BancorpSouth, Inc.(BXS)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Bancorpsouth Bank (NYSE:BXS) have received a consensus recommendation of “Hold” from the nine research firms that are currently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $35.00.

  • [By Joseph Griffin]

    Rhumbline Advisers increased its stake in shares of Bancorpsouth Bank (NYSE:BXS) by 56.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 299,547 shares of the bank’s stock after buying an additional 107,999 shares during the period. Rhumbline Advisers owned 0.33% of Bancorpsouth Bank worth $7,830,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Bancorpsouth Bank alerts:

    Bancorpsouth Bank (BXS) Expected to Announce Quarterly Sales of $215.14 Million (americanbankingnews.com) Analysts Expect Bancorpsouth Bank (BXS) Will Post Earnings of $0.55 Per Share (americanbankingnews.com) Briefs: Sunday, June 10 (djournal.com) Bancorpsouth Bank: Aktienanalyse vom 10.06.2018 (wallstreet-online.de) First State Bank Central Texas gets new name with merger (lampasasdispatchrecord.com)

    Several brokerages have recently weighed in on BXS. Stephens reissued a “buy” rating and set a $36.00 price target on shares of Bancorpsouth Bank in a research report on Friday, April 20th. Brean Capital reissued a “hold” rating on shares of Bancorpsouth Bank in a research report on Thursday, May 3rd. Zacks Investment Research raised shares of Bancorpsouth Bank from a “sell” rating to a “hold” rating in a research report on Tuesday, March 20th. Finally, ValuEngine raised shares of Bancorpsouth Bank from a “hold” rating to a “buy” rating in a research report on Saturday, May 12th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $35.00.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have impacted Accern Sentiment’s rankings:

    Get BancorpSouth Bank alerts:

    Zacks: Brokerages Anticipate BancorpSouth Bank (BXS) Will Announce Quarterly Sales of $215.14 Million (americanbankingnews.com) BancorpSouth opens on Eldorado Parkway in McKinney (communityimpact.com) Analysts Anticipate BancorpSouth Bank (BXS) to Announce $0.55 EPS (americanbankingnews.com) BancorpSouth Bank (BXS) Given Average Recommendation of “Hold” by Analysts (americanbankingnews.com)

    BXS has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of BancorpSouth Bank from a “hold” rating to a “sell” rating in a research note on Tuesday, March 27th. Hovde Group set a $35.00 price target on shares of BancorpSouth Bank and gave the company a “hold” rating in a research note on Monday, April 23rd. Piper Jaffray set a $36.00 price target on shares of BancorpSouth Bank and gave the company a “hold” rating in a research note on Monday, April 23rd. Royal Bank of Canada reaffirmed a “hold” rating and issued a $37.00 price target on shares of BancorpSouth Bank in a research note on Friday, April 20th. Finally, Brean Capital reaffirmed a “hold” rating on shares of BancorpSouth Bank in a research note on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $35.00.

  • [By Shane Hupp]

    Bancorpsouth Bank (NYSE:BXS) – FIG Partners increased their FY2019 earnings estimates for shares of Bancorpsouth Bank in a report released on Wednesday, March 6th. FIG Partners analyst J. Rodis now anticipates that the bank will post earnings of $2.41 per share for the year, up from their previous estimate of $2.40. FIG Partners also issued estimates for Bancorpsouth Bank’s Q4 2019 earnings at $0.64 EPS and FY2020 earnings at $2.56 EPS.

Top 10 Heal Care Stocks For 2019: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Alphatec (ATEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    Here are last week’s top-performing penny stocks:

    Penny Stock Sector Current Share Price Last Week’s Gain
    JMU Ltd. (NASDAQ: JMU) Utilities $2.22 133.68%
    Aquabounty Technologies Inc. (NASDAQ: AQB) Healthcare $4.89 116.37%
    Seelos Therapeutics Inc. (NASDAQ: SEEL) Healthcare $3.39 111.88%
    Iconix Brand Group Inc. (NASDAQ: ICON) Industrial Goods $0.35 84.23%
    Pulmatrix Inc. (NASDAQ: PULM) Healthcare $1.77 63.89%
    Moxian Inc. (NASDAQ: MOXC) Technologies $0.76 60.59%
    TDH Holdings Inc. (NASDAQ: PETZ) Basic Materials $0.90 57.72%
    Alphatec Holdings Inc. (NASDAQ: ATEC) Services $2.49 54.66%
    Tenax Therapeutics Inc. (NASDAQ: TENX) Services $1.99 53.08%
    Helios and Matheson Analytics Inc. (OTCMKTS: HMNY) Financial $0.01 44.91%

    As last week’s returns demonstrate, penny stocks can generate spectacular returns even when the rest of the market is dipping.

  • [By Logan Wallace]

    Media stories about Alphatec (NASDAQ:ATEC) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Alphatec earned a news impact score of 0.05 on Accern’s scale. Accern also gave news articles about the medical technology company an impact score of 47.5008469727734 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Invivo Therapeutics (NASDAQ: NVIV) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

  • [By Stephan Byrd]

    Stonepine Capital Management LLC bought a new stake in Alphatec Holdings Inc (NASDAQ:ATEC) during the 2nd quarter, HoldingsChannel.com reports. The firm bought 903,224 shares of the medical technology company’s stock, valued at approximately $2,692,000. Alphatec accounts for about 1.6% of Stonepine Capital Management LLC’s portfolio, making the stock its 17th largest holding.

  • [By Ethan Ryder]

    Alphatec (NASDAQ:ATEC) posted its quarterly earnings results on Thursday. The medical technology company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.09), Fidelity Earnings reports. The business had revenue of $22.04 million during the quarter, compared to the consensus estimate of $22.06 million.

Top 10 Heal Care Stocks For 2019: Volkswagen Aktiengesellschaft (VLKAY)

Advisors’ Opinion:

  • [By John Rosevear]

    Ionity, a German company formed late last year, has begun the process of building a network of fast-charging stations across Europe. It’s a joint venture between Ford Motor Company (NYSE:F), Mercedes-Benz parent Daimler AG (NASDAQOTH:DDAIF), BMW AG (NASDAQOTH:BAMXF), and Volkswagen AG (NASDAQOTH:VLKAY) together with its subsidiaries Porsche and Audi.

  • [By John Rosevear]

    German auto giant Volkswagen AG (NASDAQOTH:VLKAY) said that it will launch its own urban car-sharing service, starting next year in Germany and rolling out worldwide in 2020. It’s similar to existing services, but with a twist: The new service’s cars will be 100% electric.

  • [By John Rosevear]

    Volkswagen AG’s (NASDAQOTH:VLKAY) U.S. unit is teaming up with four suppliers, including chip powerhouse NVIDIA (NASDAQ:NVDA), to deal with a key technical challenge facing developers of self-driving cars: moving all the data around inside the car.

  • [By Benzinga News Desk]

    Not long after U.S. authorities filed sealed charges against Volkswagen’s (OTC: VLKAY) old chief executive officer, they granted the new CEO a rare safe-passage deal: Link

Top 10 Heal Care Stocks For 2019: Kenon Holdings Ltd.(KEN)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Monday, the utilities shares climbed 0.3 percent. Meanwhile, top gainers in the sector included Vectren Corporation (NYSE: VVC), up 6 percent, and Kenon Holdings Ltd. (NYSE: KEN), up 5 percent.

  • [By Logan Wallace]

    Kenon (NYSE: KEN) and Brookfield Infrastructure Partners (NYSE:BIP) are both utilities companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

  • [By Ethan Ryder]

    Golden Ocean Group (NASDAQ: GOGL) and Kenon (NYSE:KEN) are both small-cap transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings.

  • [By Joseph Griffin]

    Kenon (NYSE: KEN) and Odyssey Marine Exploration (NASDAQ:OMEX) are both small-cap utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Top 10 Heal Care Stocks For 2019: Citizens Financial Group, Inc.(CFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Citizens Financial Group Inc (NYSE:CFG) insider Randall J. Black sold 792 shares of Citizens Financial Group stock in a transaction on Tuesday, June 5th. The shares were sold at an average price of $41.49, for a total value of $32,860.08. Following the completion of the transaction, the insider now owns 34,258 shares in the company, valued at $1,421,364.42. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Logan Wallace]

    Citizens Financial Group Inc (NYSE:CFG) – Research analysts at Jefferies Financial Group lowered their Q3 2018 earnings per share (EPS) estimates for Citizens Financial Group in a note issued to investors on Monday, October 8th. Jefferies Financial Group analyst K. Usdin now anticipates that the bank will post earnings of $0.90 per share for the quarter, down from their previous forecast of $0.91. Jefferies Financial Group also issued estimates for Citizens Financial Group’s FY2018 earnings at $3.51 EPS and FY2020 earnings at $4.15 EPS.

  • [By Max Byerly]

    Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Lee Jackson]

    This remains a top financial pick across Wall Street. Citizens Financial Group Inc. (NYSE: CFG) operates 1,200 branches primarily throughout 11 states across the New England, Mid-Atlantic and Midwest regions. It has consolidated total assets of $150 billion, ranking as the 13th largest bank in the United States by assets. The company offers a broad range of retail and commercial banking products and services to more than 5 million individuals, institution and companies.

Top 10 Heal Care Stocks For 2019: Summit State Bank(SSBI)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

    Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Top 10 Heal Care Stocks For 2019: Arrow Financial Corporation(AROW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub cut shares of Arrow Financial (NASDAQ:AROW) from a buy rating to a hold rating in a research report report published on Tuesday morning.

  • [By Logan Wallace]

    Shares of Arrow Financial Co. (NASDAQ:AROW) reached a new 52-week high on Wednesday . The stock traded as high as $40.05 and last traded at $39.80, with a volume of 105 shares changing hands. The stock had previously closed at $40.05.

  • [By Stephan Byrd]

    News headlines about Arrow Financial (NASDAQ:AROW) have trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Arrow Financial earned a coverage optimism score of 0.09 on Accern’s scale. Accern also assigned headlines about the financial services provider an impact score of 45.9957785453404 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 10 Heal Care Stocks For 2019: National Commerce Corporation(NCOM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    The Manufacturers Life Insurance Company boosted its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 0.8% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 223,067 shares of the financial services provider’s stock after acquiring an additional 1,798 shares during the quarter. The Manufacturers Life Insurance Company owned 1.29% of National Commerce worth $9,714,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Citigroup Inc. trimmed its holdings in shares of National Commerce Corp (NASDAQ:NCOM) by 44.5% in the first quarter, Holdings Channel reports. The institutional investor owned 2,703 shares of the financial services provider’s stock after selling 2,171 shares during the period. Citigroup Inc.’s holdings in National Commerce were worth $118,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    National Commerce (NASDAQ:NCOM) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Friday.

  • [By Stephan Byrd]

    National Commerce (NASDAQ:NCOM) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

Top 10 Heal Care Stocks For 2019: region(XIV)

Advisors’ Opinion:

  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like the VelocityShares Daily Inv VIX Short Term (Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.

Top 10 Heal Care Stocks To Buy Right Now

The idea of a universal basic income is becoming increasingly popular. Five years ago, it was definitely confined to the weird fringe. But now, it is attracting interest across the political spectrum. Silicon Valley entrepreneurs, concerned about the impact of technology on traditional models of employment, are funding pilot studies and donating to research projects. Governments are evaluating its potential to replace part of their increasingly complex, expensive and inefficient welfare systems.

And now it has been endorsed by winners of the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel, commonly referred to as the economics Nobel prize. The economists were participating in the 6th Lindau meeting on economic sciences, which ran from 22nd to 26th of June this year in the picturesque town of Lindau, Germany.

Lindau Nobel Mediatheque

Sir Chris Pissarides discusses inequality at the closing session of the 6th Lindau meeting on economic sciences.

Top 10 Heal Care Stocks To Buy Right Now: BRT Realty Trust(BRT)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BRT Apartments (BRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    BRT Apartments Corp (NYSE:BRT) announced a quarterly dividend on Tuesday, June 12th, Zacks reports. Shareholders of record on Monday, June 25th will be given a dividend of 0.20 per share by the financial services provider on Friday, July 6th. This represents a $0.80 dividend on an annualized basis and a yield of 6.14%. The ex-dividend date of this dividend is Friday, June 22nd.

Top 10 Heal Care Stocks To Buy Right Now: PRGX Global, Inc.(PRGX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PRGX Global (PRGX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    PRGX Global (NASDAQ:PRGX) Director Matthew A. Drapkin purchased 35,766 shares of the company’s stock in a transaction that occurred on Thursday, May 31st. The stock was bought at an average cost of $9.64 per share, with a total value of $344,784.24. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

  • [By Max Byerly]

    PRGX Global (NASDAQ:PRGX) had its price objective boosted by B. Riley from $11.00 to $12.00 in a research note published on Wednesday. They currently have a buy rating on the business services provider’s stock. B. Riley also issued estimates for PRGX Global’s Q2 2018 earnings at ($0.07) EPS, Q3 2018 earnings at $0.08 EPS, Q4 2018 earnings at $0.27 EPS, FY2018 earnings at $0.18 EPS, Q1 2019 earnings at ($0.12) EPS, Q2 2019 earnings at ($0.05) EPS, Q3 2019 earnings at $0.17 EPS, Q4 2019 earnings at $0.32 EPS and FY2019 earnings at $0.33 EPS.

Top 10 Heal Care Stocks To Buy Right Now: Duff & Phelps Global Utility Income Fund Inc.(DPG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about Duff and Phelps Global Utlity Inm Fd (NYSE:DPG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Duff and Phelps Global Utlity Inm Fd earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media coverage about the investment management company an impact score of 48.1454031211079 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Heal Care Stocks To Buy Right Now: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Sean Williams]

    Among drug developers, none had a more disappointing quarter than small-cap, clinical-stage company Corbus Pharmaceuticals (NASDAQ:CRBP), which fell more than 17%. Corbus is associated with the marijuana industry through its lead drug lenabasum (formerly anabasum), which is an oral endocannabinoid-mimetic drug that binds with naturally occurring CB2 receptors expressed on fibroblasts and immune cells. In particular, lenabasum is being targeted at four indications: systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

  • [By Joseph Griffin]

    Corbus Pharmaceuticals (NASDAQ:CRBP) has been given a $32.00 price target by investment analysts at Cantor Fitzgerald in a research note issued to investors on Thursday. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 484.47% from the stock’s previous close.

Top 10 Heal Care Stocks To Buy Right Now: SPDR S&P 500 ETF (SPY)

Advisors’ Opinion:

  • [By Max Byerly]

    Zurcher Kantonalbank Zurich Cantonalbank trimmed its position in shares of SPDR S&P 500 Trust ETF (NYSEARCA:SPY) by 78.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,700 shares of the company’s stock after selling 6,169 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in SPDR S&P 500 Trust ETF were worth $447,000 at the end of the most recent quarter.

  • [By Javier Hasse]

    The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) tumbled 1.7 percent over the five days of the week, while the ETFMG Alternative Harvest ETF (NYSE: MJ) lost 1.8 percent. The SPDR S&P 500 ETF Trust (NYSE: SPY) gained 0.3 percent.

  • [By Elizabeth Balboa]

    The threat of such an outcome forced the euro to its 2018 nadir and catalyzed the widest gap between Italian and German 10-year bond yields in four years. iShares MSCI Italy Index (ETF) (NYSE: EWI) and the SPDR S&P 500 ETF Trust (NYSE: SPY) reacted with respective 5.7-percent and 0.7-percent dips.

Top 10 Heal Care Stocks To Buy Right Now: Grupo Aval Acciones y Valores S.A.(AVAL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Grupo Aval Acciones y Valores (AVAL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    ING Groep (NYSE: ING) and GRUPO AVAL ACCI/S (NYSE:AVAL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Top 10 Heal Care Stocks To Buy Right Now: UMH Properties Inc.(UMH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

  • [By Joseph Griffin]

    WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

Top 10 Heal Care Stocks To Buy Right Now: PriceSmart, Inc.(PSMT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    PriceSmart (NASDAQ: PSMT) is one of 12 publicly-traded companies in the “Variety stores” industry, but how does it compare to its rivals? We will compare PriceSmart to similar companies based on the strength of its dividends, institutional ownership, risk, earnings, analyst recommendations, profitability and valuation.

  • [By Demitrios Kalogeropoulos]

    Investors have some big questions heading into PriceSmart’s (NASDAQ:PSMT) upcoming quarterly report. The good news: The warehouse retailing chain is showing signs of a growth rebound that’s likely to continue as Latin American and Caribbean economies recover.

  • [By Jim Crumly]

    As for individual stocks, Biogen (NASDAQ:BIIB) made headlines with positive results from a trial of an Alzheimer’s drug, and PriceSmart (NASDAQ:PSMT) fell after reporting earnings.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PriceSmart (PSMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Buy Right Now: AAON Inc.(AAON)

Advisors’ Opinion:

  • [By Max Byerly]

    AAON (NASDAQ:AAON) – Equities researchers at DA Davidson cut their Q1 2018 earnings per share (EPS) estimates for shares of AAON in a report issued on Wednesday, April 11th. DA Davidson analyst B. Thielman now expects that the construction company will earn $0.24 per share for the quarter, down from their prior forecast of $0.25.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on AAON (AAON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    California Public Employees Retirement System lowered its stake in shares of AAON, Inc. (NASDAQ:AAON) by 24.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 117,279 shares of the construction company’s stock after selling 37,675 shares during the period. California Public Employees Retirement System’s holdings in AAON were worth $4,574,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    AAON (NASDAQ:AAON) reached a new 52-week high and low on Friday . The stock traded as low as $29.05 and last traded at $30.50, with a volume of 203355 shares trading hands. The stock had previously closed at $31.65.

Top 10 Heal Care Stocks To Buy Right Now: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Invivo Therapeutics (NASDAQ: NVIV) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Alphatec (ATEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Gold Stocks To Buy Right Now

While stocks got hammered yesterday, and pre-market open conditions suggest another down day on Wall Street, gold continues to be the shining star for investors. Early trading this morning shows gold futures continue their rally, with evolving developments surrounding the Trump White House lifting prices on the safe-haven metal to new highs.

What this means for gold, and more specifically gold mining stocks, is the potential for a sustained upward trend in prices as investors reconsider the commodity in turbulent political and economic times. Nexus Gold Corp (OTC: NXXGF), a Vancouver-based mineral resource company that develops precious metal mineral assets in premier mining districts across the globe, was recently highlighted as one of the junior gold mining stocks to watch.

Top Gold Stocks To Buy Right Now: Del Taco Restaurants, Inc.(TACO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Lord Abbett & CO. LLC trimmed its stake in Del Taco Restaurants Inc (NASDAQ:TACO) by 69.9% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 111,068 shares of the restaurant operator’s stock after selling 257,475 shares during the period. Lord Abbett & CO. LLC owned about 0.29% of Del Taco Restaurants worth $1,150,000 as of its most recent filing with the SEC.

  • [By Chris Lange]

    Del Taco Restaurants, Inc. (NASDAQ: TACO) shares saw a slight bump on Wednesday after one key analyst upped its price target on the taco chain. The upshot from this report is tasty returns for investors.

  • [By Max Byerly]

    Del Taco Restaurants Inc (NASDAQ:TACO) Director Patrick Walsh acquired 10,000 shares of the business’s stock in a transaction on Friday, May 18th. The stock was acquired at an average price of $11.43 per share, with a total value of $114,300.00. Following the transaction, the director now owns 31,866 shares in the company, valued at approximately $364,228.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

  • [By Shane Hupp]

    Del Taco Restaurants (NASDAQ: TACO) and Cheesecake Factory (NASDAQ:CAKE) are both retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation.

  • [By ]

    Del Taco Restaurants (TACO) : “We have so many others in that group, why go with this one?”

    Snap (SNAP) : “I think this one is going nowhere.”

Top Gold Stocks To Buy Right Now: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Smart Portfolios LLC acquired a new stake in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 2,906 shares of the exchange traded fund’s stock, valued at approximately $202,000.

  • [By Stephan Byrd]

    Thrivent Financial for Lutherans reduced its position in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) by 79.7% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 34,152 shares of the exchange traded fund’s stock after selling 133,919 shares during the quarter. Thrivent Financial for Lutherans’ holdings in iShares MSCI EAFE ETF were worth $2,380,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Natixis Advisors L.P. grew its stake in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 1.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 569,990 shares of the exchange traded fund’s stock after buying an additional 6,250 shares during the period. Natixis Advisors L.P.’s holdings in iShares MSCI EAFE ETF were worth $39,717,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Neumann Capital Management LLC increased its holdings in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 41.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 65,172 shares of the exchange traded fund’s stock after buying an additional 19,013 shares during the period. iShares MSCI EAFE ETF comprises approximately 2.9% of Neumann Capital Management LLC’s holdings, making the stock its 11th biggest position. Neumann Capital Management LLC’s holdings in iShares MSCI EAFE ETF were worth $4,541,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Traders sold shares of iShares MSCI EAFE Index Fund (NYSEARCA:EFA) on strength during trading on Wednesday. $85.53 million flowed into the stock on the tick-up and $155.44 million flowed out of the stock on the tick-down, for a money net flow of $69.91 million out of the stock. Of all companies tracked, iShares MSCI EAFE Index Fund had the 0th highest net out-flow for the day. iShares MSCI EAFE Index Fund traded up $0.20 for the day and closed at $66.56

  • [By Ethan Ryder]

    Stifel Financial Corp boosted its holdings in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,450,778 shares of the exchange traded fund’s stock after acquiring an additional 18,547 shares during the quarter. Stifel Financial Corp’s holdings in iShares MSCI EAFE ETF were worth $101,064,000 at the end of the most recent quarter.

Top Gold Stocks To Buy Right Now: Sun Life Financial Inc.(SLF)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sentry Investments Corp. grew its holdings in Sun Life Financial (NYSE:SLF) (TSE:SLF) by 2.3% in the first quarter, HoldingsChannel reports. The institutional investor owned 531,100 shares of the financial services provider’s stock after buying an additional 11,900 shares during the quarter. Sentry Investments Corp.’s holdings in Sun Life Financial were worth $28,101,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Max Byerly]

    Sun Life Financial (NYSE: SLF) and Scor (OTCMKTS:SCRYY) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Top Gold Stocks To Buy Right Now: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap pain stock Pain Therapeutics (NASDAQ: PTIE) has elevated short interest of 35.77% according to Highshortinterest.com. Pain Therapeuticsdevelops proprietary drugs that offer significant improvements to patients and physicians.The Companysexpertise consists of developing new drugs and guiding these through various regulatory and development pathways in preparation for their eventual commercialization with a focuson drug development efforts around disorders of the nervous system.The FDA has not yet established the safety or efficacy ofany drug candidates. Pain Therapeuticspipeline of drug assets includes:

  • [By Chris Lange]

    Pain Therapeutics Inc. (NASDAQ: PTIE) shares were destroyed on Wednesday after a vote from the U.S. Food and Drug Administration (FDA) was announced. As we have said before, the FDA has the potential to make or break biopharmaceutical companies. In this case, Pain Therapeutics has been broken.

  • [By Shane Hupp]

    Pain Therapeutics, Inc. (NASDAQ:PTIE) shares saw unusually-strong trading volume on Thursday . Approximately 1,943,577 shares changed hands during trading, an increase of 365% from the previous session’s volume of 417,896 shares.The stock last traded at $2.59 and had previously closed at $2.15.

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration’s advisory committee voted14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics(NASDAQ: PTIE).

Top Gold Stocks To Buy Right Now: Foresight Energy LP(FELP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Foresight Energy (NYSE:FELP) released its quarterly earnings results on Tuesday. The energy company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08), reports. Foresight Energy had a negative net margin of 18.78% and a negative return on equity of 3.93%.

  • [By Ethan Ryder]

    Foresight Energy (NYSE:FELP) – Analysts at B. Riley lifted their Q2 2018 earnings per share (EPS) estimates for Foresight Energy in a research report issued to clients and investors on Wednesday, May 9th. B. Riley analyst L. Pipes now forecasts that the energy company will post earnings of ($0.08) per share for the quarter, up from their previous forecast of ($0.12). B. Riley has a “Neutral” rating and a $4.00 price objective on the stock. B. Riley also issued estimates for Foresight Energy’s Q3 2018 earnings at ($0.07) EPS, Q4 2018 earnings at ($0.08) EPS, FY2018 earnings at ($0.35) EPS, FY2019 earnings at ($0.26) EPS and FY2020 earnings at ($0.39) EPS.

Top Gold Stocks To Buy Right Now: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Invivo Therapeutics (NASDAQ: NVIV) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Alphatec (ATEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Financial Stocks To Watch For 2018

DOL Fiduciary Rule Winners and Losers

DOL Fiduciary Rule Foes Say Delay Falls Short of Trump Order

Despite DOL Fiduciary Suspension, Merrill, Morgan Stanley Roll Out Products

The Securities and Exchange Commission said Wednesday that the agency has adopted amendments to increase the amount of money companies can raise through crowdfunding to adjust for inflation. 

The securities regulator also approved amendments that adjust for inflation a threshold used to determine eligibility for benefits offered to “emerging growth companies” (EGCs) under the Jumpstart Our Business Startups (JOBS) Act.

The committee voted to send Jay Clayton’s nomination to the full Senate.

You are signed up!

ThinkAdvisor and the College for Financial Planning have partnered to bring you a series of helpful educational tools that you can use to take your career to the next level. ThinkAdvisor TechCenter

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources White Paper: Creating a Successful Transition

It’s not when you retire. It’s how you retire.

Best Financial Stocks To Watch For 2018: ARIAD Pharmaceuticals Inc.(ARIA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.73 percent in trading on Monday. Meanwhile, top gainers in the sector included Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA), and VCA Inc (NASDAQ: WOOF).

Best Financial Stocks To Watch For 2018: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Rich Duprey]

    Sandstorm Gold (NYSEMKT:SAND) has outperformed the precious metal itself over the past year, with shares rising 35% year to date. Last month it reported third-quarter profits of $7 million, a big U-turn from 2015, when it suffered losses of $5.5 million. In fact, its entire operation was doing better with greater production: lower cash costs, but higher cash margins; and greater operating cash flows, all of which allowed it to pay down its revolving credit facility. That means it has no bank debt and its entire $110 million revolving credit facility is available to make acquisitions.

Best Financial Stocks To Watch For 2018: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

stock market performance

If I have to vote for one of the strangest market reactions to a quarterly report, GoPro’s (GPRO) recent Q3’17 numbers are probably on the top of my list.

First of all, GPRO’s management had guided higher two months earlier, stating revenue will be in the upper range between $290M and $310M. Not only did it beat that number (which was already something the market did not expect), but it beat it by a whopping $20M and the revenue increase was 37% Y/Y.

If that was not enough, the company reported GAAP EPS of $0.10 and adjusted EPS of $0.15, blowing the consensus by $0.13.

And the end result was that the stock was down by about 11% on the reporting date. Supposedly, the reason for the drop was guidance that called for about $470M in revenue for Q4 vs. the $520M the market was expecting.

So is the market right or wrong? The market is dead wrong, of course, it just doesn’t know it yet. To give you just one reason why the market is wrong, please take a look at the chart below:

stock market performance: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after Citron Research accused the company of fraud.

    Getty Images

    Mallinckrodt tumbled 12% to $59.60 today, while the S&P 500 declined 0.2% to 2,176.94.

    Leerink’s Jason Gerberry and Etzer Darout explain the allegations:

    Mallinckrodtshares are down -7-8% based on a short report citing CMS dashboard data which call into question Acthar Gel sales derived from government sources (CMS; Medicaid & Medicare). The report appears to overstate Acthar CMS sales as a percent of total product sales, as the methodology utilized by CMS drug spending dashboard for Medicare spend is based on gross sales, not net., although it’s unclear to what extent Acthar CMS sales are overstated.

    The report suggestsMallinckrodt mgmt understated combined Medicaid/Medicare sales on an investor call, saying it was about a little bit higher than a quarter of the business vs. gross sales on CMS dashboard implying sales were 61% of total Acthar net revenue (an apples to oranges comparison). We dont know the exact net sales of Acthar to Medicare/Medicaid, but we believe it is safe to assume Medicaid, after CPI price penalties had high discounts/rebates and assuming an 80% gross-to-net ratio on the Medicare book ($504m gross) suggests Acthar net sales would be closer to 38-45% range vs. the 61% figure cited in the short-report. Why this may matter Acthar Gel is an old product lacking good randomized, controlled data consistent with most products approved in the modern era. The report appears to be an attempt to call into question whether the government should be paying Acthars average $80-100k net price/patient/year by calling to this to the attention of government figures who have been targeting excessive drug pricing issues. This type of issue became a major headache for Mylan (MYL) investors recently with EpiPen.Mallinckrodt is presenting at a compe

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

stock market performance: WashingtonFirst Bankshares Inc(WFBI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of CASTLE CREEK CAPITAL PARTNERS IV, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CASTLE+CREEK+CAPITAL+PARTNERS+IV%2C+LP

    These are the top 5 holdings of CASTLE CREEK CAPITAL PARTNERS IV, LPGuaranty Bancorp (GBNK) – 1,448,849 shares, 39.1% of the total portfolio. MBT Financial Corp (MBTF) – 1,876,423 shares, 23.6% of the total portfolio. WashingtonFirst Bankshares Inc (WFBI) – 489,377 shares, 15.19% of the total portfolio. Shares added by 4558.07%Eastern Virginia Bankshares Inc (EVBS) – 1,061,225 shares, 12.33% of the total portfolio. First NBC Bank Holding Co (FNBC) – 2,205,382 shares, 9.78% of the total portfolio. Added: Wa

stock market performance: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

stock market performance: CGG(CGG)

Advisors’ Opinion:

  • [By Jonas Elmerraji]

    First up is French oil service firm CGG Veritas (CGG)
    . The Eurozone-based energy stock hasn’t exactly posted blockbuster performance in 2013, but investors who ignore CGG for the final stretch of the year could be making a big mistake. That’s because of a bullish technical pattern that’s emerging in shares right now.

    CGG spent most of the last eight months looking anything but bullish. But an ascending triangle pattern is changing that. The pattern is formed by horizontal resistance to the upside at $26, and uptrending support to the below shares. Basically, as CGG bounces in between those two technical levels, it’s getting squeezed closer and closer to a breakout above $26. When that happens, traders have a buy signal.

    The ascending triangle pattern in CGG Veritas isn’t exactly textbook. That’s because the setup is forming at the bottom of a downtrend, rather than in the middle of an uptrend – but it’s a mistake to get caught up on the textbook pictures of what trading patterns are supposed to look like. On a move through $26, the trading implications are just as actionable.

  • [By Lisa Levin]

    CGG SA (ADR) (NYSE: CGG) shares shot up 32 percent to $7.15 after the company reported an agreement in principle on financial restructuring plan with main creditors and DNCA.

  • [By Lisa Levin]

    Friday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from CGG SA (ADR) (NYSE: CGG) and Geospace Technologies Corporation (NASDAQ: GEOS).

stock market performance: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston